Oral Oncology
Volume 46, Issue 3 , Pages 185-189 , March 2010

The clinicopathological significance of the expression of Granzyme B in oral squamous cell carcinoma

  • Nádia Lago Costa

      Affiliations

    • Department of Stomatology (Oral Pathology), Dental School, Federal University of Goiás, Goiânia, Brazil
  • ,
  • Rita de Cássia Gonçalves Alencar

      Affiliations

    • Division of Anatomopathology and Cytopathology, Araújo Jorge Hospital, Association of Cancer Combat of Goiás, Goiânia, Brazil
  • ,
  • Marize Campos Valadares

      Affiliations

    • Laboratory of Cellular Pharmacology and Toxicology, Faculty of Pharmacy, Federal University of Goiás, Goiânia, Brazil
  • ,
  • Tarcília Aparecida Silva

      Affiliations

    • Department of Oral Surgery and Pathology, Dental School, Federal University of Minas Gerais, Belo Horizonte, Brazil
  • ,
  • Elismauro Francisco Mendonça

      Affiliations

    • Department of Stomatology (Oral Pathology), Dental School, Federal University of Goiás, Goiânia, Brazil
  • ,
  • Aline Carvalho Batista

      Affiliations

    • Department of Stomatology (Oral Pathology), Dental School, Federal University of Goiás, Goiânia, Brazil
    • Corresponding Author InformationCorresponding author. Address: Disciplina de Patologia Geral e Bucal, Faculdade de Odontologia, Universidade Federal de Goiás, Praça Universitária S/N, Setor Universitário CEP: 74605-220, Brazil. Tel./fax: +55 62 3209 6327.

Received 18 October 2009 ,Revised 28 November 2009 ,Accepted 30 November 2009.

References 

  1. Graubert TA, Ley TJ. How do lymphocytes kill tumor?. Clin Cancer Res. 1996;2(5):785–789
  2. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516
  3. Sintsov AV, Kovalenko EI, Khanin MA. Apoptosis induced by Granzyme B. Russ J Bioorganic Chem. 2008;34(6):647–654
  4. Trapani JA, Smyth MJ. Functional significance of the perforin/Granzyme cell death pathway. Nat Rev Immunol. 2002;2(10):735–747
  5. Heibein JA, Goping IS, Barry M, Pinkoski MJ, Shore GC, Green DR, et al. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J Exp Med. 2000;192(10):1391–1401
  6. Pinkoski MJ, Waterhouse NJ, Heibein JA, Wolf BB, Kuwana T, Goldstein JC, et al. Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway. J Biol Chem. 2001;276(15):12060–12067
  7. Kondo MC, Ribalta JCL, da Silva IDG, Alves MTS, de Azevedo-Fochi GR, Martins NV, et al. Granzyme B as a prognostic marker of cervical intraepithelial neoplasia. Eur J Oncol. 2005;26(1):87–89
  8. Batinac T, Zamolo G, Hadzisejdic I, Zauhar G. A comparative study of Granzyme B expression in keratoacanthoma and squamous cell carcinoma. J Dermatol Sci. 2006;44(2):109–112
  9. van Houdt IS, Sluijter BJR, Moesbergen LM, Vos WM, de Gruijl TD, Molenkamp BG, et al. Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. Int J Cancer. 2008;123(3):609–615
  10. Mulder WMC, Bloemena E, Stukart MJ, Kummer JA, Wagstaff J, Scheper RJ. T cell receptor-ζ and Granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut. 1997;40(1):113–119
  11. Cruz I, Meijer CJ, Walboomers JM, Snijders PJ, Van Der Waal I. Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinoma. Br J Cancer. 1999;81(5):881–889
  12. Zancope E, Costa NL, Junqueira-Kipnis AP, Valadares MC, Silva TA, Leles CR, et al. Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma. J Oral Pathol Med, in press.
  13. Pindborg JJ, Reichard PA, Smith CJ, Van Der Wall I. Histological typing of cancer and precancer of the oral mucosa. World Health Organization classification of tumours. Berlin: Springer-Verlag; 1997;p. 21–31
  14. Costa NL, Oton-Leite AF, Cheim-Júnior AP, Alencar RC, Bittar GO, Silva TA, et al. Density and migration of mast cells in lip squamous cell carcinoma and actinic cheilitis. Histol Histopathol. 2009;24(4):457–465
  15. Bose A, Chakraborty T, Chakraborty K, Pal S, Baral R. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells form head and neck squamous cell carcinoma patients. Cancer Immunol. 2008;8:10
  16. Zhang M, Zhang P, Zhang C, Sun J, Wang L, Li J, et al. Prognostic significance of Bcl-2 and Bax expression in the patients with oral squamous cell carcinoma. J Oral Pathol Med. 2009;38(3):307–313
  17. Camisasca DR, Honorato J, Bernard V, Silva LE, Fonseca EC, Faria PA, et al. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol. 2009;45(3):225–233
  18. Jans DA, Sutton VR, Jans P, Froelich CJ, Trapani JA. BCL-2 blocks perforin-induced nuclear translocation of granzymes concomitant with protection against the nuclear events of apoptosis. J Biol Chem. 1999;274(7):3953–3961
  19. Oudejans JJ, Harijadi H, Kummer JA, Tan IB, Bloemena E, Middeldorp JM, et al. High numbers of Granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent. J Pathol. 2002;198(4):468–475
  20. Guzman VB, Silva IDCG, Brenna SMF, Carvalho CRN, Ribalta JCL, Gerbase-DeLima M. High levels of Granzyme B expression in invasive cervical carcinoma correlates to poor response to treatment. Cancer Invest. 2008;26(5):499–503
  21. Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, et al. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer. 2009;9:292

PII: S1368-8375(09)00985-3

doi: 10.1016/j.oraloncology.2009.11.016

Oral Oncology
Volume 46, Issue 3 , Pages 185-189 , March 2010